Seres Therapeutics Reports First Quarter Financial Results and Provides Clinical Pipeline Progress Update

Go back to Seres Therapeutics Reports First Quarter Financial Results and Provides Clinical Pipeline Progress Update
(NASDAQ: MCRB) Delayed: 7.05 +0.45 (6.82%)
Previous Close $6.60    52 Week High $44.51 
Open $6.72    52 Week Low $8.05 
Day High $7.40    P/E N/A 
Day Low $6.72    EPS $0.00 
Volume 57,936